Last reviewed: June 8, 2026

Last updated: June 8, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Glucagon-like peptide-1 receptor agonists have demonstrated average weight loss of 10–15% of body weight in clinical trials, making them among the most effective weight management tools available. However, many people struggle to locate providers who offer GLP-1 therapy at prices they can afford. PlexusDx bridges this gap by providing compounded GLP-1 medications from licensed pharmacies nationwide, with options starting at $149 per month and serving all 50 states without insurance requirements.

Understanding GLP-1 Medications and How They Work

GLP-1 receptor agonists function by mimicking a natural hormone your body produces after eating. This hormone signals your brain that you are full, slowing stomach emptying and reducing hunger signals throughout the day. Semaglutide, one of the most researched compounds in this class, has been shown in STEP trials to produce sustained weight loss when combined with lifestyle changes. The medication works on multiple appetite-control pathways, which is why responses vary from person to person based on individual biology.

Two main delivery methods exist for GLP-1 therapy: injectable and oral formulations. Injectable semaglutide typically offers faster absorption and stronger clinical outcomes, while oral versions provide convenience for patients who prefer tablets. PlexusDx offers both formats, allowing you to choose based on your preferences and lifestyle. Your healthcare provider can help determine which delivery method aligns best with your treatment goals and schedule.

Why Compounded GLP-1 Offers Access and Affordability

Brand-name GLP-1 medications can cost $900–$1,500 monthly without insurance coverage, pricing many people out of treatment entirely. Compounded medications created by licensed 503A pharmacies offer clinically equivalent alternatives at a fraction of the cost. These pharmacies follow the same FDA sterility and safety standards as brand manufacturers, ensuring your medication meets rigorous quality benchmarks. PlexusDx partners exclusively with licensed 503A compounding pharmacies to guarantee consistency and safety in every dose.

Compounded semaglutide injection from PlexusDx starts at $149 per month, making GLP-1 therapy accessible to patients across income levels. No membership fees, insurance requirements, or hidden charges apply. Your dose may need to go up as your treatment progresses, but your price remains fixed—a commitment to transparent, predictable healthcare costs. HSA and FSA accounts are accepted, providing additional tax-advantaged savings for eligible patients.

How to Start GLP-1 Therapy With PlexusDx

Beginning GLP-1 treatment with PlexusDx requires three simple steps: online consultation with a licensed provider, medication selection based on your preferences and medical history, and delivery directly to your address. The entire process takes days rather than weeks, eliminating lengthy clinic wait times. PlexusDx serves all 50 states, meaning geography is never a barrier to accessing care. Your provider will review your health history, current medications, and weight loss goals to ensure GLP-1 therapy is appropriate for you.

Once approved, you choose your medication format—injection or oral—and your provider sends a prescription to PlexusDx's licensed pharmacy partners. Your first shipment includes detailed instructions on self-administration, storage, and what to expect during your first weeks of treatment. PlexusDx provides ongoing support through your provider, who monitors your progress and adjusts your plan as needed. Many patients see measurable results within 4–6 weeks, though individual timelines vary.

Personalized Treatment: The Role of Genetic Testing

Not everyone responds identically to GLP-1 therapy, and genetics play a significant role in how your body processes these medications. PlexusDx offers the Precision Peptide Genetic Test, a peptide-pathway analysis (not pharmacogenomic) that examines key variants like GIPR rs1800437, GLP1R rs6923761, and MC4R rs17782313. These genetic markers influence how your body's appetite-control systems function, helping predict which GLP-1 formulation may work best for your biology. The test maps 14 metabolic pathways and 150+ genetic insights relevant to weight management.

The Precision Peptide Genetic Test costs $99 as an add-on after your first month of treatment, allowing your provider to refine your therapy based on your genetic profile. Patients with specific variants may benefit more from semaglutide, tirzepatide, or combination approaches like GLP-Squared. This personalized approach reduces trial-and-error treatment and maximizes your chances of achieving meaningful, sustained weight loss. Your genetic data informs your provider's dose adjustments and medication selections moving forward.

PlexusDx Medication Options and Pricing

PlexusDx offers six core GLP-1 formulations to match different patient needs and budgets. Compounded semaglutide injection starts at $149 monthly and represents the most affordable entry point into GLP-1 therapy. Oral semaglutide begins at $249 per month for patients preferring tablet administration. Compounded tirzepatide injection, a dual-action GLP-1/GIP receptor agonist showing stronger weight loss in some patients, starts at $249 monthly. Tirzepatide's dual mechanism may benefit patients who have plateaued on semaglutide alone.

For advanced customization, PlexusDx offers GLP-Squared—a dual-compound injection combining semaglutide and tirzepatide in one formula, starting at $249 monthly. An oral GLP-Squared option is available at $369 per month for maximum convenience. The Microdose GLP-1 Protocol, priced at $129 monthly, suits patients seeking gentle metabolic support or those just beginning weight loss treatment. All pricing remains flat regardless of dose escalation, honoring PlexusDx's commitment: your dose may need to go up, but your price won't.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is compounded GLP-1 safe and as effective as brand-name medications?

Yes. Compounded medications from licensed 503A pharmacies meet the same FDA sterility, potency, and safety standards as brand manufacturers. PlexusDx partners exclusively with licensed 503A facilities, never 503B operations. Clinical outcomes for compounded semaglutide and tirzepatide are equivalent to their brand counterparts when prescribed at appropriate doses.

What weight loss results should I expect from semaglutide?

Clinical trials show average weight loss of 10–15% of body weight over 68 weeks with semaglutide combined with lifestyle changes. Results vary based on starting weight, adherence to diet and exercise, and individual genetics. PlexusDx's Precision Peptide Genetic Test can help predict your likely response based on your peptide-pathway biology.

How much does GLP-1 therapy cost at PlexusDx, and what payment options exist?

Compounded semaglutide injection starts at $149 per month, with no membership fees or insurance requirements. PlexusDx accepts HSA and FSA accounts for tax-advantaged savings. All pricing is flat per medication—your dose may increase without affecting your monthly cost.

What side effects should I expect, and are they dangerous?

Common early side effects include nausea, mild vomiting, and appetite changes, typically diminishing within 2–4 weeks as your body adjusts. Serious side effects are rare when prescribed appropriately. Your PlexusDx provider monitors your progress and adjusts dosing to minimize discomfort while maximizing results.

How does the Precision Peptide Genetic Test help personalize my GLP-1 therapy?

The $99 test examines genetic variants affecting appetite control and peptide responsiveness, including GIPR, GLP1R, and MC4R markers. Results help your provider select the optimal GLP-1 formulation—semaglutide, tirzepatide, or GLP-Squared—and guide dose adjustments for your unique biology. The test maps 150+ genetic insights across 14 metabolic pathways.

Related Reading

Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves